Characteristics of older adults receiving opioids in primary care: treatment duration and outcomes

M Carrington Reid, Charles R Henderson Jr, Maria Papaleontiou, Leslie Amanfo, Yelena Olkhovskaya, Alison A Moore, Sagar S Parikh, Barbara J Turner, M Carrington Reid, Charles R Henderson Jr, Maria Papaleontiou, Leslie Amanfo, Yelena Olkhovskaya, Alison A Moore, Sagar S Parikh, Barbara J Turner

Abstract

Objective: To describe characteristics of older adults who received opioids for chronic non-cancer pain (CP), ascertain types of opioid treatments received, and examine associations between patient characteristics and treatment outcomes.

Design: Retrospective cohort study.

Setting: Primary care practice in New York City.

Patients: Eligible patients were >or=65 and newly started on an opioid for CP.

Outcome measures: Patient characteristics and provider treatments, as well as duration of opioid therapy, proportion discontinuing therapy, and evidence of pain reduction and continued use of opioid for more than 1 year. Other outcomes included the presence and type(s) of side effects, abuse/misuse behaviors, and adverse events.

Results: Participants (N = 133) had a mean age of 82 (range = 65-105), were mostly female (84%), and white (74%). Common indications for opioid treatment included back pain (37%) and osteoarthritis (35%). Mean duration of opioid use was 388 days (range = 0-1,880). Short-acting analgesics were most commonly prescribed. Physicians recorded side effects in 40% of cases. Opioids were discontinued in 48% of cases, mostly due to side effects/lack of efficacy. Pain reduction was documented in 66% of patient records, while 32% reported less pain and continued treatment for >or=1 year. Three percent displayed abuse/misuse behaviors, and 5% were hospitalized due to opioid-related adverse events.

Conclusions: Over 50% of older patients with CP tolerated treatment. Treatment was discontinued in 48% of cases, mostly due to side effects and lack of analgesic efficacy. Efforts are needed to establish the long-term safety and efficacy of opioid treatment for CP in diverse older patient populations.

Source: PubMed

3
Abonnere